BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Allavena P, Germano G, Marchesi F, Mantovani A. Chemokines in cancer related inflammation. Exp Cell Res. 2011;317:664-673. [PMID: 21134366 DOI: 10.1016/j.yexcr.2010.11.013] [Cited by in Crossref: 148] [Cited by in F6Publishing: 123] [Article Influence: 13.5] [Reference Citation Analysis]
Number Citing Articles
1 Rojas A, Araya P, Romero J, Delgado-López F, Gonzalez I, Añazco C, Perez-Castro R. Skewed Signaling through the Receptor for Advanced Glycation End-Products Alters the Proinflammatory Profile of Tumor-Associated Macrophages. Cancer Microenviron 2018;11:97-105. [PMID: 30091031 DOI: 10.1007/s12307-018-0214-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
2 Umansky V, Sevko A. Overcoming immunosuppression in the melanoma microenvironment induced by chronic inflammation. Cancer Immunol Immunother 2012;61:275-82. [PMID: 22120757 DOI: 10.1007/s00262-011-1164-6] [Cited by in Crossref: 47] [Cited by in F6Publishing: 40] [Article Influence: 4.7] [Reference Citation Analysis]
3 Paulino DSM, Mendes MCS, Camargo JA, Brambilla SR, Wood Dos Santos T, Ribeiro ML, Carvalheira JBC. Diacerein treatment prevents colitis-associated cancer in mice. World J Clin Oncol 2020;11:732-46. [PMID: 33033695 DOI: 10.5306/wjco.v11.i9.732] [Reference Citation Analysis]
4 Ding L, Li B, Zhao Y, Fu YF, Hu EL, Hu QG, Ni YH, Hou YY. Serum CCL2 and CCL3 as potential biomarkers for the diagnosis of oral squamous cell carcinoma. Tumour Biol 2014;35:10539-46. [PMID: 25060177 DOI: 10.1007/s13277-014-2306-1] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
5 Chopra A, Judson MA. How are cancer and connective tissue diseases related to sarcoidosis? Curr Opin Pulm Med 2015;21:517-24. [PMID: 26132816 DOI: 10.1097/MCP.0000000000000186] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
6 Novillo A, Gaibar M, Romero-Lorca A, Gilsanz MF, Beltrán L, Galán M, Antón B, Malón D, Moreno A, Fernández-Santander A. Efficacy of bevacizumab-containing chemotherapy in metastatic colorectal cancer and CXCL5 expression: Six case reports. World J Gastroenterol 2020;26:1979-86. [PMID: 32390708 DOI: 10.3748/wjg.v26.i16.1979] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
7 Lee SJ, Kim JE, Kim ST, Lee J, Park SH, Park JO, Kang WK, Park YS, Lim HY. The Correlation Between Serum Chemokines and Clinical Outcome in Patients with Advanced Biliary Tract Cancer. Transl Oncol 2018;11:353-7. [PMID: 29448202 DOI: 10.1016/j.tranon.2018.01.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
8 Rolin J, Maghazachi AA. Implications of chemokine receptors and inflammatory lipids in cancer. Immunotargets Ther 2014;3:9-18. [PMID: 27471696 DOI: 10.2147/ITT.S32049] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
9 Yang D, Zhou J, Zeng T, Yang Z, Wang X, Hu J, Song Y, Chen L, Peer D, Wang X, Bai C. Serum chemokine network correlates with chemotherapy in non-small cell lung cancer. Cancer Lett 2015;365:57-67. [PMID: 25976768 DOI: 10.1016/j.canlet.2015.05.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
10 Fang WB, Yao M, Cheng N. Priming cancer cells for drug resistance: role of the fibroblast niche. Front Biol (Beijing) 2014;9:114-26. [PMID: 25045348 DOI: 10.1007/s11515-014-1300-8] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 3.4] [Reference Citation Analysis]
11 Li YL, Shi ZH, Wang X, Gu KS, Zhai ZM. Prognostic significance of monocyte chemoattractant protein-1 and CC chemokine receptor 2 in diffuse large B cell lymphoma. Ann Hematol 2019;98:413-22. [PMID: 30374624 DOI: 10.1007/s00277-018-3522-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
12 Altevogt P, Bretz NP, Ridinger J, Utikal J, Umansky V. Novel insights into exosome-induced, tumor-associated inflammation and immunomodulation. Semin Cancer Biol. 2014;28:51-57. [PMID: 24769223 DOI: 10.1016/j.semcancer.2014.04.008] [Cited by in Crossref: 46] [Cited by in F6Publishing: 49] [Article Influence: 6.6] [Reference Citation Analysis]
13 Meneses-Echávez JF, González-Jiménez E, Ramírez-Vélez R. Effects of Supervised Multimodal Exercise Interventions on Cancer-Related Fatigue: Systematic Review and Meta-Analysis of Randomized Controlled Trials. Biomed Res Int 2015;2015:328636. [PMID: 26167483 DOI: 10.1155/2015/328636] [Cited by in Crossref: 50] [Cited by in F6Publishing: 35] [Article Influence: 8.3] [Reference Citation Analysis]
14 Zhu X, Sun Y, Zhang Y, Su X, Luo C, Alarifi S, Yang H. Dieckol alleviates dextran sulfate sodium-induced colitis via inhibition of inflammatory pathway and activation of Nrf2/HO-1 signaling pathway. Environ Toxicol 2021;36:782-8. [PMID: 33331035 DOI: 10.1002/tox.23080] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
15 Nielsen N, Lindemann O, Schwab A. TRP channels and STIM/ORAI proteins: sensors and effectors of cancer and stroma cell migration. Br J Pharmacol 2014;171:5524-40. [PMID: 24724725 DOI: 10.1111/bph.12721] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 5.0] [Reference Citation Analysis]
16 Wang Z, Liu H, Shen Z, Wang X, Zhang H, Qin J, Xu J, Sun Y, Qin X. The prognostic value of CXC-chemokine receptor 2 (CXCR2) in gastric cancer patients. BMC Cancer 2015;15:766. [PMID: 26497045 DOI: 10.1186/s12885-015-1793-9] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
17 Schmieder A, Michel J, Schönhaar K, Goerdt S, Schledzewski K. Differentiation and gene expression profile of tumor-associated macrophages. Semin Cancer Biol 2012;22:289-97. [PMID: 22349514 DOI: 10.1016/j.semcancer.2012.02.002] [Cited by in Crossref: 139] [Cited by in F6Publishing: 119] [Article Influence: 15.4] [Reference Citation Analysis]
18 Germano G, Mantovani A, Allavena P. Targeting of the innate immunity/inflammation as complementary anti-tumor therapies. Annals of Medicine 2011;43:581-93. [DOI: 10.3109/07853890.2011.595732] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
19 Chen GY, Liu M, Wang F, Bertin J, Núñez G. A functional role for Nlrp6 in intestinal inflammation and tumorigenesis. J Immunol 2011;186:7187-94. [PMID: 21543645 DOI: 10.4049/jimmunol.1100412] [Cited by in Crossref: 278] [Cited by in F6Publishing: 255] [Article Influence: 27.8] [Reference Citation Analysis]
20 Xiao P, Long X, Zhang L, Ye Y, Guo J, Liu P, Zhang R, Ning J, Yu W, Wei F, Yu J. Neurotensin/IL-8 pathway orchestrates local inflammatory response and tumor invasion by inducing M2 polarization of Tumor-Associated macrophages and epithelial-mesenchymal transition of hepatocellular carcinoma cells. Oncoimmunology 2018;7:e1440166. [PMID: 29900041 DOI: 10.1080/2162402X.2018.1440166] [Cited by in Crossref: 43] [Cited by in F6Publishing: 25] [Article Influence: 14.3] [Reference Citation Analysis]
21 Zhao L, Lim SY, Gordon-Weeks AN, Tapmeier TT, Im JH, Cao Y, Beech J, Allen D, Smart S, Muschel RJ. Recruitment of a myeloid cell subset (CD11b/Gr1 mid) via CCL2/CCR2 promotes the development of colorectal cancer liver metastasis. Hepatology. 2013;57:829-839. [PMID: 23081697 DOI: 10.1002/hep.26094] [Cited by in Crossref: 139] [Cited by in F6Publishing: 127] [Article Influence: 17.4] [Reference Citation Analysis]
22 Morisaki T, Umebayashi M, Kiyota A, Koya N, Tanaka H, Onishi H, Katano M. Combining cetuximab with killer lymphocytes synergistically inhibits human cholangiocarcinoma cells in vitro. Anticancer Res. 2012;32:2249-2256. [PMID: 22641659 DOI: 10.1016/j.semcancer.2012.03.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
23 Mukaida N, Baba T. Chemokines in tumor development and progression. Exp Cell Res. 2012;318:95-102. [PMID: 22036649 DOI: 10.1016/j.yexcr.2011.10.012] [Cited by in Crossref: 58] [Cited by in F6Publishing: 54] [Article Influence: 5.8] [Reference Citation Analysis]
24 Wu M, Swartz MA. Modeling tumor microenvironments in vitro. J Biomech Eng 2014;136:021011. [PMID: 24402507 DOI: 10.1115/1.4026447] [Cited by in Crossref: 30] [Cited by in F6Publishing: 21] [Article Influence: 4.3] [Reference Citation Analysis]
25 Sumsuzzman DM, Jin Y, Choi J, Yu J, Lee TH, Hong Y. Pathophysiological role of endogenous irisin against tumorigenesis and metastasis: Is it a potential biomarker and therapeutic? Tumour Biol 2019;41:101042831989279. [DOI: 10.1177/1010428319892790] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
26 Hu B, Fan H, Lv X, Chen S, Shao Z. Prognostic significance of CXCL5 expression in cancer patients: a meta-analysis. Cancer Cell Int. 2018;18:68. [PMID: 29743818 DOI: 10.1186/s12935-018-0562-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
27 Huang WS, Chen CN, Sze CI, Teng CC. Visfatin induces stromal cell-derived factor-1 expression by β1 integrin signaling in colorectal cancer cells. J Cell Physiol. 2013;228:1017-1024. [PMID: 23042611 DOI: 10.1002/jcp.24248] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 3.1] [Reference Citation Analysis]
28 Hu H, Wu LL, Han T, Zhuo M, Lei W, Cui JJ, Jiao F, Wang LW. Correlated high expression of FXR and Sp1 in cancer cells confers a poor prognosis for pancreatic cancer: A study based on TCGA and tissue microarray. Oncotarget 2017;8:33265-75. [PMID: 28402278 DOI: 10.18632/oncotarget.16633] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
29 Chen X, Wang Y, Nelson D, Tian S, Mulvey E, Patel B, Conti I, Jaen J, Rollins BJ. CCL2/CCR2 Regulates the Tumor Microenvironment in HER-2/neu-Driven Mammary Carcinomas in Mice. PLoS One 2016;11:e0165595. [PMID: 27820834 DOI: 10.1371/journal.pone.0165595] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 5.0] [Reference Citation Analysis]
30 Cardona SM, Garcia JA, Cardona AE. The fine balance of chemokines during disease: trafficking, inflammation, and homeostasis. Methods Mol Biol 2013;1013:1-16. [PMID: 23625489 DOI: 10.1007/978-1-62703-426-5_1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
31 Wang Y, Yin C, Geng L, Cai W. Immune Infiltration Landscape in Clear Cell Renal Cell Carcinoma Implications. Front Oncol 2020;10:491621. [PMID: 33665156 DOI: 10.3389/fonc.2020.491621] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
32 Mir MA, Maurer MJ, Ziesmer SC, Slager SL, Habermann T, Macon WR, Link BK, Syrbu S, Witzig T, Friedberg JW. Elevated serum levels of IL-2R, IL-1RA, and CXCL9 are associated with a poor prognosis in follicular lymphoma. Blood. 2015;125:992-998. [PMID: 25422100 DOI: 10.1182/blood-2014-06-583369] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 4.7] [Reference Citation Analysis]
33 Kundu JK, Surh YJ. Emerging avenues linking inflammation and cancer. Free Radic Biol Med. 2012;52:2013-2037. [PMID: 22391222 DOI: 10.1016/j.freeradbiomed.2012.02.035] [Cited by in Crossref: 162] [Cited by in F6Publishing: 131] [Article Influence: 18.0] [Reference Citation Analysis]
34 Croce L, Coperchini F, Magri F, Chiovato L, Rotondi M. The multifaceted anti-cancer effects of BRAF-inhibitors. Oncotarget 2019;10:6623-40. [PMID: 31762942 DOI: 10.18632/oncotarget.27304] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 10.5] [Reference Citation Analysis]
35 Acuner-Ozbabacan ES, Engin BH, Guven-Maiorov E, Kuzu G, Muratcioglu S, Baspinar A, Chen Z, Van Waes C, Gursoy A, Keskin O, Nussinov R. The structural network of Interleukin-10 and its implications in inflammation and cancer. BMC Genomics 2014;15 Suppl 4:S2. [PMID: 25056661 DOI: 10.1186/1471-2164-15-S4-S2] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 4.3] [Reference Citation Analysis]
36 Spella M, Stathopoulos GT. Immune Resistance in Lung Adenocarcinoma. Cancers (Basel) 2021;13:384. [PMID: 33494181 DOI: 10.3390/cancers13030384] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
37 Vela M, Aris M, Llorente M, Garcia-Sanz JA, Kremer L. Chemokine receptor-specific antibodies in cancer immunotherapy: achievements and challenges. Front Immunol 2015;6:12. [PMID: 25688243 DOI: 10.3389/fimmu.2015.00012] [Cited by in Crossref: 59] [Cited by in F6Publishing: 62] [Article Influence: 9.8] [Reference Citation Analysis]
38 She Z, Zhang T, Wang X, Li X, Song Y, Cheng X, Huang Z, Deng Y. The anticancer efficacy of pixantrone-loaded liposomes decorated with sialic acid–octadecylamine conjugate. Biomaterials 2014;35:5216-25. [DOI: 10.1016/j.biomaterials.2014.03.022] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 4.6] [Reference Citation Analysis]
39 Borsig L, Wolf MJ, Roblek M, Lorentzen A, Heikenwalder M. Inflammatory chemokines and metastasis--tracing the accessory. Oncogene. 2014;33:3217-3224. [PMID: 23851506 DOI: 10.1038/onc.2013.272] [Cited by in Crossref: 129] [Cited by in F6Publishing: 124] [Article Influence: 16.1] [Reference Citation Analysis]
40 Wang HM, Lin TL, Kuo YC, Li HP, Chang KP, Lin CY, Fan HC, Lin AC, Hsieh CH, Tsang NM, Lee LY, Chan SC, Lui KW, Chang YS, Hsu CL. Correlation between overall survival and differential plasma and tissue tumor marker expression in nasopharyngeal carcinoma patients with different sites of organ metastasis. Oncotarget 2016;7:53217-29. [PMID: 27448966 DOI: 10.18632/oncotarget.10676] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
41 Rotondi M, Coperchini F, Latrofa F, Chiovato L. Role of Chemokines in Thyroid Cancer Microenvironment: Is CXCL8 the Main Player? Front Endocrinol (Lausanne) 2018;9:314. [PMID: 29977225 DOI: 10.3389/fendo.2018.00314] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 9.7] [Reference Citation Analysis]
42 Lin SS, Fan W, Sun L, Li FF, Zhao RP, Zhang LY, Yu BY, Yuan ST. The saponin DT-13 inhibits gastric cancer cell migration through down-regulation of CCR5-CCL5 axis. Chin J Nat Med 2014;12:833-40. [PMID: 25480514 DOI: 10.1016/S1875-5364(14)60125-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
43 Khan MN, Wang B, Wei J, Zhang Y, Li Q, Luan X, Cheng JW, Gordon JR, Li F, Liu H. CXCR1/2 antagonism with CXCL8/Interleukin-8 analogue CXCL8(3-72)K11R/G31P restricts lung cancer growth by inhibiting tumor cell proliferation and suppressing angiogenesis. Oncotarget 2015;6:21315-27. [PMID: 26087179 DOI: 10.18632/oncotarget.4066] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 6.6] [Reference Citation Analysis]
44 Galmarini CM, D'Incalci M, Allavena P. Trabectedin and plitidepsin: drugs from the sea that strike the tumor microenvironment. Mar Drugs 2014;12:719-33. [PMID: 24473171 DOI: 10.3390/md12020719] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 4.1] [Reference Citation Analysis]
45 Li C, Cheung MKH, Han S, Zhang Z, Chen L, Chen J, Zeng H, Qiu J. Mesenchymal stem cells and their mitochondrial transfer: a double-edged sword. Biosci Rep 2019;39:BSR20182417. [PMID: 30979829 DOI: 10.1042/BSR20182417] [Cited by in Crossref: 25] [Cited by in F6Publishing: 14] [Article Influence: 12.5] [Reference Citation Analysis]
46 Choi K, Komurov K, Fletcher JS, Jousma E, Cancelas JA, Wu J, Ratner N. An inflammatory gene signature distinguishes neurofibroma Schwann cells and macrophages from cells in the normal peripheral nervous system. Sci Rep 2017;7:43315. [PMID: 28256556 DOI: 10.1038/srep43315] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
47 Samaniego R, Estecha A, Relloso M, Longo N, Escat JL, Longo-Imedio I, Avilés JA, del Pozo MA, Puig-Kröger A, Sánchez-Mateos P. Mesenchymal contribution to recruitment, infiltration, and positioning of leukocytes in human melanoma tissues. J Invest Dermatol 2013;133:2255-64. [PMID: 23446986 DOI: 10.1038/jid.2013.88] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
48 Montinaro A, Iannone R, Pinto A, Morello S. Adenosine receptors as potential targets in melanoma. Pharmacological Research 2013;76:34-40. [DOI: 10.1016/j.phrs.2013.07.002] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
49 Estko M, Baumgartner S, Urech K, Kunz M, Regueiro U, Heusser P, Weissenstein U. Tumour cell derived effects on monocyte/macrophage polarization and function and modulatory potential of Viscum album lipophilic extract in vitro. BMC Complement Altern Med 2015;15:130. [PMID: 25902944 DOI: 10.1186/s12906-015-0650-3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
50 Wang J, Shu M, Wang Y, Hu Y, Wang Y, Luo Y, Lin Z. Identification of potential CCR5 inhibitors through pharmacophore-based virtual screening, molecular dynamics simulation and binding free energy analysis. Mol BioSyst 2016;12:3396-406. [DOI: 10.1039/c6mb00577b] [Cited by in Crossref: 7] [Article Influence: 1.4] [Reference Citation Analysis]
51 Mazzoccoli G, Sothern RB, Parrella P, Muscarella LA, Fazio VM, Giuliani F, Polyakova V, Kvetnoy IM. Comparison of circadian characteristics for cytotoxic lymphocyte subsets in non-small cell lung cancer patients versus controls. Clin Exp Med 2012;12:181-94. [PMID: 21910027 DOI: 10.1007/s10238-011-0153-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
52 Vaassen LA, Speel EM, Kessler PA. Bone invasion by oral squamous cell carcinoma: Molecular alterations leading to osteoclastogenesis – a review of literature. Journal of Cranio-Maxillofacial Surgery 2017;45:1464-71. [DOI: 10.1016/j.jcms.2017.04.012] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
53 Askari H, Rajani SF, Poorebrahim M, Haghi-Aminjan H, Raeis-Abdollahi E, Abdollahi M. A glance at the therapeutic potential of irisin against diseases involving inflammation, oxidative stress, and apoptosis: An introductory review. Pharmacol Res. 2018;129:44-55. [PMID: 29414191 DOI: 10.1016/j.phrs.2018.01.012] [Cited by in Crossref: 50] [Cited by in F6Publishing: 47] [Article Influence: 16.7] [Reference Citation Analysis]
54 Skeate JG, Otsmaa ME, Prins R, Fernandez DJ, Da Silva DM, Kast WM. TNFSF14: LIGHTing the Way for Effective Cancer Immunotherapy. Front Immunol 2020;11:922. [PMID: 32499782 DOI: 10.3389/fimmu.2020.00922] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 10.0] [Reference Citation Analysis]
55 Mendes MCS, Paulino DS, Brambilla SR, Camargo JA, Persinoti GF, Carvalheira JBC. Microbiota modification by probiotic supplementation reduces colitis associated colon cancer in mice. World J Gastroenterol 2018;24:1995-2008. [PMID: 29760543 DOI: 10.3748/wjg.v24.i18.1995] [Cited by in CrossRef: 49] [Cited by in F6Publishing: 40] [Article Influence: 16.3] [Reference Citation Analysis]
56 Zhang L, Reddy N, Koyyalamudi SR. Isolation, Characterization, and Biological Activities of Polysaccharides from Medicinal Plants and Mushrooms. Elsevier; 2014. pp. 117-51. [DOI: 10.1016/b978-0-444-63281-4.00005-7] [Cited by in Crossref: 8] [Article Influence: 1.1] [Reference Citation Analysis]
57 Le Page C, Marineau A, Bonza PK, Rahimi K, Cyr L, Labouba I, Madore J, Delvoye N, Mes-Masson AM, Provencher DM, Cailhier JF. BTN3A2 expression in epithelial ovarian cancer is associated with higher tumor infiltrating T cells and a better prognosis. PLoS One 2012;7:e38541. [PMID: 22685580 DOI: 10.1371/journal.pone.0038541] [Cited by in Crossref: 55] [Cited by in F6Publishing: 49] [Article Influence: 6.1] [Reference Citation Analysis]
58 Łukaszewicz-Zając M, Pączek S, Muszyński P, Kozłowski M, Mroczko B. Comparison between clinical significance of serum CXCL-8 and classical tumor markers in oesophageal cancer (OC) patients. Clin Exp Med 2019;19:191-9. [PMID: 30820705 DOI: 10.1007/s10238-019-00548-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
59 Ding J, Sui D, Liu M, Su Y, Wang Y, Liu M, Luo X, Liu X, Deng Y, Song Y. Sialic acid conjugate-modified liposomes enable tumor homing of epirubicin via neutrophil/monocyte infiltration for tumor therapy. Acta Biomater 2021:S1742-7061(21)00501-8. [PMID: 34339869 DOI: 10.1016/j.actbio.2021.07.063] [Reference Citation Analysis]
60 Keinänen A, Uittamo J, Marinescu-Gava M, Kainulainen S, Snäll J. Preoperative C-reactive protein to albumin ratio and oral health in oral squamous cell carcinoma patients. BMC Oral Health 2021;21:132. [PMID: 33740951 DOI: 10.1186/s12903-021-01516-0] [Reference Citation Analysis]
61 Guzman NA, Phillips TM. Immunoaffinity capillary electrophoresis: A new versatile tool for determining protein biomarkers in inflammatory processes. ELECTROPHORESIS 2011. [DOI: 10.1002/elps.201000700] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
62 Lappano R, Maggiolini M. Pharmacotherapeutic Targeting of G Protein-Coupled Receptors in Oncology: Examples of Approved Therapies and Emerging Concepts. Drugs 2017;77:951-65. [PMID: 28401445 DOI: 10.1007/s40265-017-0738-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
63 Sanjeewa KKA, Nagahawatta DP, Yang HW, Oh JY, Jayawardena TU, Jeon YJ, De Zoysa M, Whang I, Ryu B. Octominin Inhibits LPS-Induced Chemokine and Pro-inflammatory Cytokine Secretion from RAW 264.7 Macrophages via Blocking TLRs/NF-κB Signal Transduction. Biomolecules 2020;10:E511. [PMID: 32230927 DOI: 10.3390/biom10040511] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 13.0] [Reference Citation Analysis]
64 Zhan Y, Chen PJ, Sadler WD, Wang F, Poe S, Núñez G, Eaton KA, Chen GY. Gut microbiota protects against gastrointestinal tumorigenesis caused by epithelial injury. Cancer Res 2013;73:7199-210. [PMID: 24165160 DOI: 10.1158/0008-5472.CAN-13-0827] [Cited by in Crossref: 63] [Cited by in F6Publishing: 43] [Article Influence: 7.9] [Reference Citation Analysis]
65 Vecchio E, Fiume G, Mignogna C, Iaccino E, Mimmi S, Maisano D, Trapasso F, Quinto I. IBTK Haploinsufficiency Affects the Tumor Microenvironment of Myc-Driven Lymphoma in E-myc Mice. Int J Mol Sci 2020;21:E885. [PMID: 32019112 DOI: 10.3390/ijms21030885] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
66 Li XP, Yang XY, Biskup E, Zhou J, Li HL, Wu YF, Chen ML, Xu F. Co-expression of CXCL8 and HIF-1α is associated with metastasis and poor prognosis in hepatocellular carcinoma. Oncotarget 2015;6:22880-9. [PMID: 26078356 DOI: 10.18632/oncotarget.4412] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 6.6] [Reference Citation Analysis]
67 Zhang M, Zhang L, Cui M, Ye W, Zhang P, Zhou S, Wang J. miR-302b inhibits cancer-related inflammation by targeting ERBB4, IRF2 and CXCR4 in esophageal cancer. Oncotarget 2017;8:49053-63. [PMID: 28467773 DOI: 10.18632/oncotarget.17041] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
68 Park JH, Rasch MG, Qiu J, Lund IK, Egeblad M. Presence of insulin-like growth factor binding proteins correlates with tumor-promoting effects of matrix metalloproteinase 9 in breast cancer. Neoplasia 2015;17:421-33. [PMID: 26025665 DOI: 10.1016/j.neo.2015.04.003] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]
69 Wolf MJ, Hoos A, Bauer J, Boettcher S, Knust M, Weber A, Simonavicius N, Schneider C, Lang M, Stürzl M, Croner RS, Konrad A, Manz MG, Moch H, Aguzzi A, van Loo G, Pasparakis M, Prinz M, Borsig L, Heikenwalder M. Endothelial CCR2 signaling induced by colon carcinoma cells enables extravasation via the JAK2-Stat5 and p38MAPK pathway. Cancer Cell 2012;22:91-105. [PMID: 22789541 DOI: 10.1016/j.ccr.2012.05.023] [Cited by in Crossref: 182] [Cited by in F6Publishing: 162] [Article Influence: 20.2] [Reference Citation Analysis]
70 Fernandes JV, Cobucci RN, Jatobá CA, Fernandes TA, de Azevedo JW, de Araújo JM. The role of the mediators of inflammation in cancer development. Pathol Oncol Res. 2015;21:527-534. [PMID: 25740073 DOI: 10.1007/s12253-015-9913-z] [Cited by in Crossref: 106] [Cited by in F6Publishing: 87] [Article Influence: 17.7] [Reference Citation Analysis]
71 Richardsen E, Ness N, Melbø-jørgensen C, Johannesen C, Grindstad T, Nordbakken C, Al-saad S, Andersen S, Dønnem T, Nordby Y, Bremnes RM, Busund L. The Prognostic Significance of CXCL16 and Its Receptor C-X-C Chemokine Receptor 6 in Prostate Cancer. The American Journal of Pathology 2015;185:2722-30. [DOI: 10.1016/j.ajpath.2015.06.013] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]
72 Taverna G, Pedretti E, Di Caro G, Borroni EM, Marchesi F, Grizzi F. Inflammation and prostate cancer: friends or foe? Inflamm Res 2015;64:275-86. [PMID: 25788425 DOI: 10.1007/s00011-015-0812-2] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 5.2] [Reference Citation Analysis]
73 Aldinucci D, Casagrande N. Inhibition of the CCL5/CCR5 Axis against the Progression of Gastric Cancer. Int J Mol Sci 2018;19:E1477. [PMID: 29772686 DOI: 10.3390/ijms19051477] [Cited by in Crossref: 53] [Cited by in F6Publishing: 43] [Article Influence: 17.7] [Reference Citation Analysis]
74 Comai S, Bertazzo A, Brughera M, Crotti S. Tryptophan in health and disease. Adv Clin Chem. 2020;95:165-218. [PMID: 32122523 DOI: 10.1016/bs.acc.2019.08.005] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 11.5] [Reference Citation Analysis]
75 Lanitis E, Dangaj D, Irving M, Coukos G. Mechanisms regulating T-cell infiltration and activity in solid tumors. Ann Oncol 2017;28:xii18-32. [PMID: 29045511 DOI: 10.1093/annonc/mdx238] [Cited by in Crossref: 130] [Cited by in F6Publishing: 114] [Article Influence: 43.3] [Reference Citation Analysis]
76 Giotopoulou GA, Stathopoulos GT. Effects of Inhaled Tobacco Smoke on the Pulmonary Tumor Microenvironment. Adv Exp Med Biol 2020;1225:53-69. [PMID: 32030647 DOI: 10.1007/978-3-030-35727-6_4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
77 Wang J, Li D, Cang H, Guo B. Crosstalk between cancer and immune cells: Role of tumor-associated macrophages in the tumor microenvironment. Cancer Med 2019;8:4709-21. [PMID: 31222971 DOI: 10.1002/cam4.2327] [Cited by in Crossref: 62] [Cited by in F6Publishing: 55] [Article Influence: 31.0] [Reference Citation Analysis]
78 Yapa S, Mulla O, Green V, England J, Greenman J. The Role of Chemokines in Thyroid Carcinoma. Thyroid 2017;27:1347-59. [PMID: 28891394 DOI: 10.1089/thy.2016.0660] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
79 Owen JL, Mohamadzadeh M. Macrophages and chemokines as mediators of angiogenesis. Front Physiol. 2013;4:159. [PMID: 23847541 DOI: 10.3389/fphys.2013.00159] [Cited by in Crossref: 80] [Cited by in F6Publishing: 82] [Article Influence: 10.0] [Reference Citation Analysis]
80 Zheng X, Rui S, Wang XF, Zou XH, Gong YP, Li ZH. circPVT1 regulates medullary thyroid cancer growth and metastasis by targeting miR-455-5p to activate CXCL12/CXCR4 signaling. J Exp Clin Cancer Res 2021;40:157. [PMID: 33962657 DOI: 10.1186/s13046-021-01964-0] [Reference Citation Analysis]
81 Umansky V, Sevko A. Melanoma-induced immunosuppression and its neutralization. Semin Cancer Biol 2012;22:319-26. [PMID: 22349515 DOI: 10.1016/j.semcancer.2012.02.003] [Cited by in Crossref: 80] [Cited by in F6Publishing: 70] [Article Influence: 8.9] [Reference Citation Analysis]
82 Piao C, Zhang WM, Li TT, Zhang CC, Qiu S, Liu Y, Liu S, Jin M, Jia LX, Song WC, Du J. Complement 5a stimulates macrophage polarization and contributes to tumor metastases of colon cancer. Exp Cell Res 2018;366:127-38. [PMID: 29551360 DOI: 10.1016/j.yexcr.2018.03.009] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 8.7] [Reference Citation Analysis]
83 Cuenca AG, Cuenca AL, Winfield RD, Joiner DN, Gentile L, Delano MJ, Kelly-Scumpia KM, Scumpia PO, Matheny MK, Scarpace PJ, Vila L, Efron PA, LaFace DM, Moldawer LL. Novel role for tumor-induced expansion of myeloid-derived cells in cancer cachexia. J Immunol 2014;192:6111-9. [PMID: 24829407 DOI: 10.4049/jimmunol.1302895] [Cited by in Crossref: 36] [Cited by in F6Publishing: 28] [Article Influence: 5.1] [Reference Citation Analysis]
84 Ran S, Montgomery KE. Macrophage-mediated lymphangiogenesis: the emerging role of macrophages as lymphatic endothelial progenitors. Cancers (Basel) 2012;4:618-57. [PMID: 22946011 DOI: 10.3390/cancers4030618] [Cited by in Crossref: 83] [Cited by in F6Publishing: 74] [Article Influence: 9.2] [Reference Citation Analysis]
85 Taccioli C, Chen H, Jiang Y, Liu XP, Huang K, Smalley KJ, Farber JL, Croce CM, Fong LY. Dietary zinc deficiency fuels esophageal cancer development by inducing a distinct inflammatory signature. Oncogene 2012;31:4550-8. [PMID: 22179833 DOI: 10.1038/onc.2011.592] [Cited by in Crossref: 46] [Cited by in F6Publishing: 43] [Article Influence: 4.6] [Reference Citation Analysis]
86 Ishida Y, Kuninaka Y, Yamamoto Y, Nosaka M, Kimura A, Furukawa F, Mukaida N, Kondo T. Pivotal Involvement of the CX3CL1-CX3CR1 Axis for the Recruitment of M2 Tumor-Associated Macrophages in Skin Carcinogenesis. J Invest Dermatol 2020;140:1951-1961.e6. [PMID: 32179066 DOI: 10.1016/j.jid.2020.02.023] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
87 Mukaida N, Sasaki S, Baba T. Chemokines in cancer development and progression and their potential as targeting molecules for cancer treatment. Mediators Inflamm. 2014;2014:170381. [PMID: 24966464 DOI: 10.1155/2014/170381] [Cited by in Crossref: 63] [Cited by in F6Publishing: 65] [Article Influence: 9.0] [Reference Citation Analysis]
88 Kavandi L, Collier MA, Nguyen H, Syed V. Progesterone and calcitriol attenuate inflammatory cytokines CXCL1 and CXCL2 in ovarian and endometrial cancer cells. J Cell Biochem. 2012;113:3143-3152. [PMID: 22615136 DOI: 10.1002/jcb.24191] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 4.0] [Reference Citation Analysis]
89 Guven-Maiorov E, Acuner-Ozbabacan SE, Keskin O, Gursoy A, Nussinov R. Structural pathways of cytokines may illuminate their roles in regulation of cancer development and immunotherapy. Cancers (Basel) 2014;6:663-83. [PMID: 24670367 DOI: 10.3390/cancers6020663] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
90 Hoos A, Wolf MJ, Bauer J, Borsig L, Heikenwalder M. Endothelial chemokine receptors as facilitators of tumor cell extravasation? Oncotarget 2012;3:919-20. [PMID: 23007072 DOI: 10.18632/oncotarget.672] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
91 Kim MJ, Sun HJ, Song YS, Yoo SK, Kim YA, Seo JS, Park YJ, Cho SW. CXCL16 positively correlated with M2-macrophage infiltration, enhanced angiogenesis, and poor prognosis in thyroid cancer. Sci Rep 2019;9:13288. [PMID: 31527616 DOI: 10.1038/s41598-019-49613-z] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 8.5] [Reference Citation Analysis]
92 Costantini S, Romano G, Rusolo F, Capone F, Guerriero E, Colonna G, Ianora A, Ciliberto G, Costantini M. Anti-Inflammatory Effects of a Methanol Extract from the Marine Sponge Geodia cydonium on the Human Breast Cancer MCF-7 Cell Line. Mediators Inflamm. 2015;2015:204975. [PMID: 26491222 DOI: 10.1155/2015/204975] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
93 Berlato C, Khan MN, Schioppa T, Thompson R, Maniati E, Montfort A, Jangani M, Canosa M, Kulbe H, Hagemann UB, Duncan AR, Fletcher L, Wilkinson RW, Powles T, Quezada SA, Balkwill FR. A CCR4 antagonist reverses the tumor-promoting microenvironment of renal cancer. J Clin Invest 2017;127:801-13. [PMID: 28134623 DOI: 10.1172/JCI82976] [Cited by in Crossref: 38] [Cited by in F6Publishing: 22] [Article Influence: 9.5] [Reference Citation Analysis]
94 Roblek M, Strutzmann E, Zankl C, Adage T, Heikenwalder M, Atlic A, Weis R, Kungl A, Borsig L. Targeting of CCL2-CCR2-Glycosaminoglycan Axis Using a CCL2 Decoy Protein Attenuates Metastasis through Inhibition of Tumor Cell Seeding. Neoplasia 2016;18:49-59. [PMID: 26806351 DOI: 10.1016/j.neo.2015.11.013] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 4.2] [Reference Citation Analysis]
95 Nan Y, Du J, Ma L, Jiang H, Jin F, Yang S. Early Candidate Biomarkers of Non-Small Cell Lung Cancer Are Screened and Identified in Premalignant Lung Lesions. Technol Cancer Res Treat 2017;16:66-74. [PMID: 26809240 DOI: 10.1177/1533034615627391] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
96 Putz EM, Hoelzl MA, Baeck J, Bago-Horvath Z, Schuster C, Reichholf B, Kern D, Aberger F, Sexl V, Hoelbl-Kovacic A. Loss of STAT3 in Lymphoma Relaxes NK Cell-Mediated Tumor Surveillance. Cancers (Basel) 2014;6:193-210. [PMID: 24473086 DOI: 10.3390/cancers6010193] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
97 Pham T, Roth S, Kong J, Guerra G, Narasimhan V, Pereira L, Desai J, Heriot A, Ramsay R. An Update on Immunotherapy for Solid Tumors: A Review. Ann Surg Oncol 2018;25:3404-12. [DOI: 10.1245/s10434-018-6658-4] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 8.0] [Reference Citation Analysis]
98 Seoane S, Martinez-Ordoñez A, Eiro N, Cabezas-Sainz P, Garcia-Caballero L, Gonzalez LO, Macia M, Sanchez L, Vizoso F, Perez-Fernandez R. POU1F1 transcription factor promotes breast cancer metastasis via recruitment and polarization of macrophages. J Pathol 2019;249:381-94. [PMID: 31292963 DOI: 10.1002/path.5324] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
99 Mukaida N, Sasakki S, Popivanova BK. Tumor Necrosis Factor (TNF) and Chemokines in Colitis-Associated Cancer. Cancers (Basel) 2011;3:2811-26. [PMID: 24212934 DOI: 10.3390/cancers3032811] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
100 Bruzzone S, Parenti MD, Grozio A, Ballestrero A, Bauer I, Del Rio A, Nencioni A. Rejuvenating sirtuins: the rise of a new family of cancer drug targets. Curr Pharm Des 2013;19:614-23. [PMID: 23016857 DOI: 10.2174/138161213804581954] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 3.6] [Reference Citation Analysis]
101 Jiang H, Gebhardt C, Umansky L, Beckhove P, Schulze TJ, Utikal J, Umansky V. Elevated chronic inflammatory factors and myeloid-derived suppressor cells indicate poor prognosis in advanced melanoma patients. Int J Cancer. 2015;136:2352-2360. [PMID: 25353097 DOI: 10.1002/ijc.29297] [Cited by in Crossref: 89] [Cited by in F6Publishing: 82] [Article Influence: 12.7] [Reference Citation Analysis]
102 Manček-keber M, Lainšček D, Benčina M, Chen JG, Romih R, Hunter ZR, Treon SP, Jerala R. Extracellular vesicle–mediated transfer of constitutively active MyD88L265P engages MyD88wt and activates signaling. Blood 2018;131:1720-9. [DOI: 10.1182/blood-2017-09-805499] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 8.7] [Reference Citation Analysis]
103 Cai FF, Xu C, Pan X, Cai L, Lin XY, Chen S, Biskup E. Prognostic value of plasma levels of HIF-1a and PGC-1a in breast cancer. Oncotarget 2016;7:77793-806. [PMID: 27780920 DOI: 10.18632/oncotarget.12796] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 8.7] [Reference Citation Analysis]
104 Taverna G, Giusti G, Seveso M, Hurle R, Colombo P, Stifter S, Grizzi F. Mast cells as a potential prognostic marker in prostate cancer. Dis Markers 2013;35:711-20. [PMID: 24324287 DOI: 10.1155/2013/478303] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
105 Puig-Costa M, Codina-Cazador A, Cortés-Pastoret E, Oliveras-Ferraros C, Cufí S, Flaquer S, Llopis-Puigmarti F, Pujol-Amado E, Corominas-Faja B, Cuyàs E, Ortiz R, Lopez-Bonet E, Queralt B, Guardeño R, Martin-Castillo B, Roig J, Joven J, Menendez JA. Discovery and validation of an INflammatory PROtein-driven GAstric cancer Signature (INPROGAS) using antibody microarray-based oncoproteomics. Oncotarget 2014;5:1942-54. [PMID: 24722433 DOI: 10.18632/oncotarget.1879] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
106 Moyano Cardaba C, Jacques R, Barrett J, Hassell K, Kavanagh A, Remington F, Tse T, Mueller A. CCL3 induced migration occurs independently of intracellular calcium release. Biochemical and Biophysical Research Communications 2012;418:17-21. [DOI: 10.1016/j.bbrc.2011.12.081] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
107 Mantovani A, Galdiero MR, Allavena P, Sica A. Tumor-associated Macrophages in Cancer Growth and Progression. Cancer Immunotherapy. Elsevier; 2013. pp. 451-71. [DOI: 10.1016/b978-0-12-394296-8.00027-0] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
108 Ding J, Zhao D, Hu Y, Liu M, Liao X, Zhao B, Liu X, Deng Y, Song Y. Terminating the renewal of tumor-associated macrophages: A sialic acid-based targeted delivery strategy for cancer immunotherapy. International Journal of Pharmaceutics 2019;571:118706. [DOI: 10.1016/j.ijpharm.2019.118706] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
109 Zhu Z, Shen Z, Xu C. Inflammatory pathways as promising targets to increase chemotherapy response in bladder cancer. Mediators Inflamm 2012;2012:528690. [PMID: 22811589 DOI: 10.1155/2012/528690] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 3.8] [Reference Citation Analysis]
110 Zhang F, Yuan Y, Li H, Shen L, Guo Y, Wen Z, Pu X. Using accelerated molecular dynamics simulation to shed light on the mechanism of activation/deactivation upon mutations for CCR5. RSC Adv 2018;8:37855-65. [DOI: 10.1039/c8ra07686c] [Cited by in Crossref: 4] [Article Influence: 1.3] [Reference Citation Analysis]
111 Sleightholm RL, Neilsen BK, Li J, Steele MM, Singh RK, Hollingsworth MA, Oupicky D. Emerging roles of the CXCL12/CXCR4 axis in pancreatic cancer progression and therapy. Pharmacol Ther. 2017;179:158-170. [PMID: 28549596 DOI: 10.1016/j.pharmthera.2017.05.012] [Cited by in Crossref: 63] [Cited by in F6Publishing: 64] [Article Influence: 15.8] [Reference Citation Analysis]
112 Aldinucci D, Colombatti A. The inflammatory chemokine CCL5 and cancer progression. Mediators Inflamm 2014;2014:292376. [PMID: 24523569 DOI: 10.1155/2014/292376] [Cited by in Crossref: 201] [Cited by in F6Publishing: 191] [Article Influence: 28.7] [Reference Citation Analysis]
113 Balkwill FR. The chemokine system and cancer. J Pathol. 2012;226:148-157. [PMID: 21989643 DOI: 10.1002/path.3029] [Cited by in Crossref: 264] [Cited by in F6Publishing: 250] [Article Influence: 26.4] [Reference Citation Analysis]
114 Tsang JYS, Hui S, Ni Y, Chan S, Yamaguchi R, Kwong A, Law BKB, Tse GM. Lymphocytic infiltrate is associated with favorable biomarkers profile in HER2-overexpressing breast cancers and adverse biomarker profile in ER-positive breast cancers. Breast Cancer Res Treat 2014;143:1-9. [DOI: 10.1007/s10549-013-2781-x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
115 Park HC, Kim MY, Kim CH. C-reactive protein/albumin ratio as prognostic score in oral squamous cell carcinoma. J Korean Assoc Oral Maxillofac Surg 2016;42:243-50. [PMID: 27847731 DOI: 10.5125/jkaoms.2016.42.5.243] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
116 Maxwell PJ, Coulter J, Walker SM, McKechnie M, Neisen J, McCabe N, Kennedy RD, Salto-Tellez M, Albanese C, Waugh DJ. Potentiation of Inflammatory CXCL8 Signalling Sustains Cell Survival in PTEN-deficient Prostate Carcinoma. Eur Urol. 2012;Epub ahead of print. [PMID: 22939387 DOI: 10.1016/j.eururo.2012.08.032] [Cited by in Crossref: 48] [Cited by in F6Publishing: 45] [Article Influence: 5.3] [Reference Citation Analysis]
117 Kalvakolanu DV. Cytokine signaling in cancer: Novel players and pathways. Cytokine 2017;89:1-3. [PMID: 27894807 DOI: 10.1016/j.cyto.2016.11.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
118 Yang GS, Mi X, Jackson-Cook CK, Starkweather AR, Lynch Kelly D, Archer KJ, Zou F, Lyon DE. Differential DNA methylation following chemotherapy for breast cancer is associated with lack of memory improvement at one year. Epigenetics 2020;15:499-510. [PMID: 31793401 DOI: 10.1080/15592294.2019.1699695] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
119 D'Agostino G, Cecchinato V, Uguccioni M. Chemokine Heterocomplexes and Cancer: A Novel Chapter to Be Written in Tumor Immunity. Front Immunol 2018;9:2185. [PMID: 30319638 DOI: 10.3389/fimmu.2018.02185] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
120 Seifert M, Garbe M, Friedrich B, Mittelbronn M, Klink B. Comparative transcriptomics reveals similarities and differences between astrocytoma grades. BMC Cancer 2015;15:952. [PMID: 26673168 DOI: 10.1186/s12885-015-1939-9] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 3.5] [Reference Citation Analysis]
121 Vered M, Fürth E, Shalev Y, Dayan D. Inflammatory cells of immunosuppressive phenotypes in oral lichen planus have a proinflammatory pattern of expression and are associated with clinical parameters. Clin Oral Invest 2013;17:1365-73. [DOI: 10.1007/s00784-012-0814-1] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
122 Kovacs G, Peterfi L, Farkas N, Javorhazy A, Pusztai C, Szanto A. Expression of inflammatory lipopolysaccharide binding protein (LBP) predicts the progression of conventional renal cell carcinoma - a short report. Cell Oncol (Dordr) 2017;40:651-6. [PMID: 28936621 DOI: 10.1007/s13402-017-0346-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
123 Lasry A, Ben-Neriah Y. Senescence-associated inflammatory responses: aging and cancer perspectives. Trends Immunol. 2015;36:217-228. [PMID: 25801910 DOI: 10.1016/j.it.2015.02.009] [Cited by in Crossref: 184] [Cited by in F6Publishing: 147] [Article Influence: 30.7] [Reference Citation Analysis]